anticorps APRIL, anticorps PHAPI2, anticorps SSP29, anticorps 2410015B15Rik, anticorps PAL31, anticorps PHAPI2a, anticorps Ssp29, anticorps cb908, anticorps fa99a11, anticorps wu:fa28c10, anticorps wu:fa99a11, anticorps wu:fb40e12, anticorps zgc:77745, anticorps hLAMP-1, anticorps MGC80871, anticorps ANP32B, anticorps MGC69373, anticorps SLAN, anticorps acidic nuclear phosphoprotein 32 family member B, anticorps acidic (leucine-rich) nuclear phosphoprotein 32 family, member B, anticorps acidic nuclear phosphoprotein 32 family member B L homeolog, anticorps acidic leucine-rich nuclear phosphoprotein 32 family member B, anticorps ANP32B, anticorps Anp32b, anticorps anp32b, anticorps anp32b.L, anticorps LOC494442
Sujet
ANP32B is a member of the highly conserved acidic leucine-rich nuclear phosphoprotein 32 (ANP32) family. The ANP32 proteins have been implicated in a broad array of physiological processes, including cell differentiation, apoptotic cell death, and cell proliferation. ANP32B was identified as a novel direct substrate for caspase-3 and acted as a negative regulator for leukemic cell apoptosis. ANP32B controls the expression of the dendritic cell maturation factor CD83 by regulating the transport of its mRNA to the cytoplasm. It also modulates the activity of the transcription factor Kruppel-like factor 5 (KLF5).